Renaissance Capital logo

TTPH News

US IPO Weekly Recap: Seven deals price, six new filers

style="margin: 0px; font-family: arial, sans-serif; font-size: 13px; line-height: 18px; color: rgb(51, 51, 51); background-color: white;">After a slow start to March in which only three deals priced, the third week of the month saw seven companies debut. Th...read more

Tetraphase Pharmaceutical prices IPO below the range at $7, raising $75 million

Tetraphase Pharmaceuticals, which is developing antibiotics to treat serious abdominal and urinary tract infections, raised $75 million by offering 10.7 million shares at $7, below the revised range of $8 to $10. The company had originally filed to offer 6.8...read more

Tetraphase Pharmaceuticals increases shares, decreases range for $75 million IPO

Tetraphase Pharmaceuticals, which is developing antibiotics to treat serious abdominal and urinary tract infections, revised the terms for its upcoming IPO, though it maintained the deal size. The Watertown, MA-based company still plans to raise $75 million, but...read more

9 US IPOs planned for the week of Mar 18

The following IPOs are expected to price this week: Aviv REIT (AVIV), a REIT specializing in post-acute and long-term care skilled nursing facilities, plans to raise...read more